Development of an integrated management platform to provide a more efficient and effective system to manage and control clinical trials

开发综合管理平台，提供更高效、更有效的临床试验管理和控制系统

• 批准号: 86393
• 金额: $ 12.7万
• 依托单位: PHARMASEAL INTERNATIONAL LIMITED
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2020
• 资助国家: 英国
• 起止时间: 2020 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=86393
• 关键词: Development; integrated; management; platform; provide

The clinical trial process has become increasingly fragmented and requires outsourcing, which has had a significantly negative impact on the cost and time taken to develop and approve novel medicines. The current COVID-19 pandemic has highlighted a need for a digital tool that will allow the virtualisation of clinical trials, while the current economic climate demands a cost-effective solution. PHARMASEAL, founded by Daljit Cheema, Ricky Lakhani, Hugh O'Neil, and Lorin Thwaits, aims to provide a digital integrated management system that will reduce both the costs and time associated with each clinical trial.

临床试验过程变得越来越分散，需要外包，这对开发和批准新药的成本和时间产生了重大的负面影响。当前的COVID-19大流行凸显了对一种数字化工具的需求，这种工具将使临床试验虚拟化，而当前的经济环境需要一种具有成本效益的解决方案。PHARMASEAL由Daljit Cheema、Ricky Lakhani、Hugh O'Neil和Lorin Thwaits创立，旨在提供一个数字集成管理系统，以减少与每次临床试验相关的成本和时间。